Bingqiu Q. Xiu
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.
Journal: World journal of surgical oncology
Published: March 30, 2026
Restoring the CD226 in CD8+T cells overcomes TIGIT-refractory immunity in HER2+ breast cancer.
Journal: Cell death & disease
Published: January 06, 2026
Current landscape and challenges in autologous breast reconstruction across China: A nationwide questionnaire-based survey of 198 hospitals.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Published: August 09, 2025
Shifting Practice Patterns in Implant-based Breast Reconstruction in China: Insights From a 13-year Large-scale Retrospective Cohort.
Journal: Plastic and reconstructive surgery. Global open
Published: August 04, 2025
Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 11, 2025
Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey.
Journal: Aesthetic plastic surgery
Published: June 13, 2025
Current practices and trends of breast-conserving surgery in China: A nationwide cross-sectional survey.
Journal: Chinese medical journal
Published: May 08, 2025
Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.
Journal: Journal of surgical oncology
Published: May 02, 2025
Current Practices and Evolving Trends in Implant-based Breast Reconstruction in China: A Nationwide Cross-sectional Survey.
Journal: Plastic and reconstructive surgery. Global open
Published: April 18, 2025
A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.
Journal: International journal of surgery (London, England)
Published: April 09, 2025
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer.
Journal: Biomarker research
Published: April 04, 2025
Last Updated: 09/26/2026